PlainPharmaWatch

CMS Open Payments · Program Year 2024

BeiGene AUS Pty Ltd

BeiGene AUS Pty Ltd reported $3,238,961.12 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 825 transactions.

See the rankings → How this is sourced
$3.2M
All-tracks total
825
Transactions
0
Recipients
#347
of 1,925 companies

BeiGene AUS Pty Ltd reported $3,238,961.12 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #347 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer beigene-aus-pty-ltd BeiGene AUS Pty Ltd

$3.2M · #347/1,925 · 0.0% industry · PY2024

  • TOT $3.2M
  • RANK #347
  • SHARE 0.0%
  • TXN 825
  • RCP 0
  • CAT 0
  • GEN n/a
  • PY 2024

Volume peers

Nearest volume peer: Phasor Health, LLC ($3.2M)

Chugai Pharmaceutical Co., L…$3.2MEndo USA, Inc.$3.2MBeiGene AUS Pty Ltd (this)$3.2MPhasor Health, LLC$3.2MViseon, Inc.$3.2M
All-tracks payment totals near BeiGene AUS Pty Ltd (CMS Open Payments PY2024)

BeiGene AUS Pty Ltd sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for BeiGene AUS Pty Ltd

Rank #347 of 1,925 companies in CMS Open Payments for 2024 belongs to BeiGene AUS Pty Ltd, which reported $3,238,961.12 across 825 transactions to 0 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $3.9K per transaction and $0.00 per recipient.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with BeiGene AUS Pty Ltd.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download BeiGene AUS Pty Ltd's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.